Evidence map›Paper›PMID 36524293›Full record

ArticleTechnology in cancer research & treatment

Evaluate the Prognosis of

Jin Cao, Juan J Gu, Yichen Liang, Buhai Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. The regulation roles of miRNAs in Helicobacter pylori infection.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jin CaoMedical College, 38043Yangzhou University, Yangzhou, Jiangsu, China.ORCID 0000-0002-5433-2911
Juan J GuMedical College, 38043Yangzhou University, Yangzhou, Jiangsu, China.
Yichen LiangInstitute of Oncology, 370089Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
Buhai WangMedical College, 38043Yangzhou University, Yangzhou, Jiangsu, China.
Northern Jiangsu People's Hospital · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene Proteins c-mycTumor Suppressor Protein p53East Asian PeopleErbB ReceptorsHigh-Throughput Nucleotide SequencingHumansMutationPrognosisProtein Kinase InhibitorsRetrospective StudiesEGFR protein, humanErbB ReceptorsProtein Kinase InhibitorsProto-Oncogene Proteins c-mycTP53 protein, humanTumor Suppressor Protein p53comutationEGFREGFR tyrosine kinase inhibitors (TKIs)MYCnext-Generation sequencing (NGS)non-small-cell lung cancer (NSCLC)TP53

Identifiers

PMID36524293
PMCPMC9761218
OpenAlexW4312130019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.